Article
B lymphocytes from patients with a hypomorphic mutation in STAT3 resist Epstein-Barr virus-driven cell proliferation.
Journal of virology - 1 Jan 2014
Koganti Siva, de la Paz Amanda, Freeman Alexandra F, Bhaduri-McIntosh Sumita
Abstract excerpt
Epstein-Barr virus (EBV) oncogenes exert potent B cell proliferative effects. EBV infection gives rise to B cell lines that readily proliferate in culture. This ability of EBV represents a powerful tool to study cell proliferation. In efforts to delineate the contribution of signal transducer and activator of transcription 3 (STAT3) toward EBV-driven cell proliferation, we have discovered that B cells from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
